Title : TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.

Pub. Date : 2020 Jul 24

PMID : 32722340






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy. Paclitaxel tumor protein p53 Homo sapiens
2 In the Ramucirumab/Paclitaxel group, 29/48 (60.4%) patients had TP53 mutations. Paclitaxel tumor protein p53 Homo sapiens